Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin

Figure 4

Effect of PC content and liposomal composition on mean diameters ((a), (b)) and size distribution ((c)–(f)) of the indicated ivermectin formulations. Bars in (a) and (b) correspond to -average (filled bars), mean by number (open bars), and mean by volume (striped bars). Curves in (c) and (e) correspond to #PC3-Ch1-ive0.1 (plain lines) and #PC9-Ch1-ive1.0 (dashed lines) liposomes; curves in (d) and (f) correspond to #PC3-Br1-ive0.1 (plain lines) and #PC9-Br1-ive1.0 (dashed lines) liposomes.

(a)

(b)

(c)

(d)

(e)

(f)